Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes: what a difference a decade makes. Circulation [Internet]. 2011;124(19):2145–54. https://doi.org/10.1161/CIRCULATIONAHA.110.968792.
Healy B. The Yentl syndrome. N Engl J Med [Internet]. 1991;325(4):274–6. https://doi.org/10.1056/NEJM199107253250408.
Article CAS PubMed Google Scholar
Lundberg GP, Mehta LS, Sanghani RM, Patel HN, Aggarwal NR, Aggarwal NT, et al. Heart centers for women: historical perspective on formation and future strategies to reduce cardiovascular disease. Circulation [Internet]. 2018;138(11):1155–65. https://doi.org/10.1161/CIRCULATIONAHA.118.035351.
Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation [Internet]. 2022;145(8):e153-639. https://doi.org/10.1161/CIR.0000000000001052.
CDC. Heart disease facts [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2022 Sep 1]. Available from: http://cdc.gov/heartdisease/facts.htm
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation [Internet]. 1998;97(18):1837–47. https://doi.org/10.1161/01.cir.97.18.1837.
Article CAS PubMed Google Scholar
Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS, et al. Long-term cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol [Internet]. 2019;74(22):2743–54. https://doi.org/10.1016/j.jacc.2019.09.052.
•O’Kelly AC, Michos ED, Shufelt CL, Vermunt JV, Minissian MB, Quesada O, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res [Internet]. 2022;130(4):652–72. https://doi.org/10.1161/CIRCRESAHA.121.319895. This review emphasizes on the major gender-specific risk factors especially the pregnancy-associated risk enhancers with special mention on cardiovascular disease and menopause/hormonal therapy.
Article CAS PubMed Google Scholar
Remsberg KE, Demerath EW, Schubert CM, Chumlea WC, Sun SS, Siervogel RM. Early menarche and the development of cardiovascular disease risk factors in adolescent girls: the Fels Longitudinal Study. J Clin Endocrinol Metab [Internet]. 2005;90(5):2718–24. https://doi.org/10.1210/jc.2004-1991.
Article CAS PubMed Google Scholar
Lee JJ, Cook-Wiens G, Johnson BD, Braunstein GD, Berga SL, Stanczyk FZ, et al. Age at menarche and risk of cardiovascular disease outcomes: findings from the national heart lung and blood institute-sponsored Women’s Ischemia Syndrome Evaluation. J Am Heart Assoc [Internet]. 2019;8(12):e012406. https://doi.org/10.1161/JAHA.119.012406.
Article CAS PubMed Google Scholar
Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, et al. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA [Internet]. 2019;322(24):2411–21. https://doi.org/10.1001/jama.2019.19191.
Rivera CM, Grossardt BR, Rhodes DJ, Brown RD Jr, Roger VL, Melton LJ 3rd, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause [Internet]. 2009;16(1):15–23. https://doi.org/10.1097/gme.0b013e31818888f7.
Zhu D, Chung H-F, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health [Internet]. 2019;4(11):e553-64. https://doi.org/10.1016/S2468-2667(19)30155-0.
Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol [Internet]. 1995;15(7):821–6. https://doi.org/10.1161/01.atv.15.7.821.
Article CAS PubMed Google Scholar
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril [Internet]. 2018;110(3):364–79. https://doi.org/10.1016/j.fertnstert.2018.05.004.
Harvey RE, Coffman KE, Miller VM. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond Engl) [Internet]. 2015;11(2):239–57. https://doi.org/10.2217/whe.14.64.
Hoopes AJ, Simmons KB, Godfrey EM, Sucato GS. 2016 updates to US medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use: highlights for adolescent patients. J Pediatr Adolesc Gynecol [Internet]. 2017;30(2):149–55. https://doi.org/10.1016/j.jpag.2017.01.013.
•Lindley KJ, Bairey Merz CN, Davis MB, Madden T, Park K, Bello NA, et al. Contraception and reproductive planning for women with cardiovascular disease: JACC focus seminar 5/5. J Am Coll Cardiol [Internet]. 2021;77(14):1823–34. https://doi.org/10.1016/j.jacc.2021.02.025.Lindley et al. summarize the importance of safe use of contraceptives in women with cardiovascular diseases. They illustrate a tier-based classification based on 1-year failure rates which helps in choosing safer as well as effective options in women.
Howard BV, Rossouw JE. Estrogens and cardiovascular disease risk revisited: the Women’s Health Initiative. Curr Opin Lipidol [Internet]. 2013;24(6):493–9. https://doi.org/10.1097/MOL.0000000000000022.
Article CAS PubMed Google Scholar
Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med [Internet]. 2003;349(6):523–34. https://doi.org/10.1056/NEJMoa030808.
Article CAS PubMed Google Scholar
Kealey A. Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol [Internet]. 2010;26(6):185–9. https://doi.org/10.1016/s0828-282x(10)70397-4.
Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio ALP, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J [Internet]. 2017;38(3):143–53. https://doi.org/10.1093/eurheartj/ehw149.
Smilowitz NR, Gupta N, Guo Y, Weinberg C, Reynolds H, Bangalore S. Acute myocardial infarction during pregnancy and the puerperium in the United States. J Am Coll Cardiol [Internet]. 2018;71(11):A5. https://doi.org/10.1016/s0735-1097(18)30546-1.
Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol [Internet]. 2005;105(3):480–4. https://doi.org/10.1097/01.AOG.0000151998.50852.31.
James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation [Internet]. 2006;113(12):1564–71. https://doi.org/10.1161/CIRCULATIONAHA.105.576751.
Knight M, on behalf of the MBRRACE-UK collaboration, Nair M, Brocklehurst P, Kenyon S, Neilson J, et al. Examining the impact of introducing ICD-MM on observed trends in maternal mortality rates in the UK 2003–13. BMC Pregnancy Childbirth [Internet]. 2016;16(1). https://doi.org/10.1186/s12884-016-0959-z
Tweet MS, Miller VM, Hayes SN. The evidence on estrogen, progesterone, and spontaneous coronary artery dissection. JAMA Cardiol [Internet]. 2019;4(5):403–4. https://doi.org/10.1001/jamacardio.2019.0774.
Hayes SN, Kim E, Saw J. Spontaneous coronary artery dissection: current state of the science: a scientific state from the American Heart Association. Am Heart Assoc Circ. 2018;137:e523–7.
Rose E, Gedela M, Miller N, Carpenter PL. Pregnancy-related spontaneous coronary artery dissection: a case series and literature review. J Emerg Med [Internet]. 2017;52(6):867–74. https://doi.org/10.1016/j.jemermed.2017.02.015.
Tweet MS, Hayes SN, Codsi E, Gulati R, Rose CH, Best PJM. Spontaneous coronary artery dissection associated with pregnancy. J Am Coll Cardiol [Internet]. 2017;70(4):426–35. https://doi.org/10.1016/j.jacc.2017.05.055.
Slavich M, Patel RS. Coronary artery spasm: current knowledge and residual uncertainties. Int J Cardiol Heart Vasc [Internet]. 2016;10:47–53. https://doi.org/10.1016/j.ijcha.2016.01.003.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J. ESC Guidelines for the management of cardiovascular disease during pregnancy. Eur Heart J. 2018;39:3165–241.
Adlam D, Cuculi F, Lim C, Banning A. Management of spontaneous coronary artery dissection in the primary percutaneous coronary intervention era. J Invasive Cardiol. 2010;22(11):549–53.
Vijayaraghavan R, Verma S, Gupta N, Saw J. Pregnancy-related spontaneous coronary artery dissection. Circulation [Internet]. 2014;130(21):1915–20. https://doi.org/10.1161/CIRCULATIONAHA.114.011422.
Vesga-López O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry [Internet]. 2008;65(7):805–15. https://doi.org/10.1001/archpsyc.65.7.805.
Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med [Internet]. 2000;160(12):1818–23. https://doi.org/10.1001/archinte.160.12.1818.
Article CAS PubMed Google Scholar
Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Peri
Comments (0)